Saurabh Saha - Net Worth and Insider Trading
Saurabh Saha Net Worth
The estimated net worth of Saurabh Saha is at least $336,300 dollars as of 2024-05-17. Saurabh Saha is the CEO of Centessa Pharmaceuticals PLC and owns about 38,000 shares of Centessa Pharmaceuticals PLC (CNTA) stock worth over $336,300. Details can be seen in Saurabh Saha's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Saurabh Saha has not made any transactions after 2022-06-24 and currently still holds the listed stock(s).
Transaction Summary of Saurabh Saha
Saurabh Saha Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Saurabh Saha owns 2 companies in total, including Centessa Pharmaceuticals PLC (CNTA) , and Clarivate PLC (CLVT) .
Click here to see the complete history of Saurabh Saha’s form 4 insider trades.
Insider Ownership Summary of Saurabh Saha
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| CNTA | Centessa Pharmaceuticals PLC | 2022-06-24 | director & Chief Executive Officer |
| CLVT | Clarivate PLC | 2023-05-04 | director |
Saurabh Saha Latest Holdings Summary
Saurabh Saha currently owns a total of 1 stock. Saurabh Saha owns 38,000 shares of Centessa Pharmaceuticals PLC (CNTA) as of June 24, 2022, with a value of $336,300.
Latest Holdings of Saurabh Saha
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| CNTA | Centessa Pharmaceuticals PLC | 2022-06-24 | 38,000 | 8.85 | 336,300 |
Holding Weightings of Saurabh Saha
Saurabh Saha Form 4 Trading Tracker
According to the SEC Form 4 filings, Saurabh Saha has made a total of 3 transactions in Centessa Pharmaceuticals PLC (CNTA) over the past 5 years, including 3 buys and 0 sells. The most-recent trade in Centessa Pharmaceuticals PLC is the acquisition of 10,000 shares on June 24, 2022, which cost Saurabh Saha around $46,300.
Insider Trading History of Saurabh Saha
- 1
Saurabh Saha Trading Performance
GuruFocus tracks the stock performance after each of Saurabh Saha's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Saurabh Saha is -12.08%. GuruFocus also compares Saurabh Saha's trading performance to market benchmark return within the same time period. The performance of stocks bought by Saurabh Saha within 3 months outperforms 1 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Saurabh Saha's insider trading performs compared to the benchmark.
Performance of Saurabh Saha
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | -7.42 | | | | | |
| Relative Return to S&P 500(%) | -6.15 | | | | | |
Saurabh Saha Ownership Network
Saurabh Saha Owned Company Details
What does Centessa Pharmaceuticals PLC do?
Who are the key executives at Centessa Pharmaceuticals PLC?
Saurabh Saha is the director & Chief Executive Officer of Centessa Pharmaceuticals PLC. Other key executives at Centessa Pharmaceuticals PLC include Chief People Officer Karen M. Anderson , SVP Regulatory Affairs Harris Rotman , and Chief Medical Officer Antoine Yver .
Centessa Pharmaceuticals PLC (CNTA) Insider Trades Summary
Over the past 18 months, Saurabh Saha made no insider transaction in Centessa Pharmaceuticals PLC (CNTA). Other recent insider transactions involving Centessa Pharmaceuticals PLC (CNTA) include a net sale of 44,370 shares made by Antoine Yver , a net sale of 41,751 shares made by Harris Rotman , and a net sale of 51,160 shares made by Karen M. Anderson .
In summary, during the past 3 months, insiders sold 51,160 shares of Centessa Pharmaceuticals PLC (CNTA) in total and bought 0 shares, with a net sale of 51,160 shares. During the past 18 months, 145,281 shares of Centessa Pharmaceuticals PLC (CNTA) were sold and 0 shares were bought by its insiders, resulting in a net sale of 145,281 shares.
Centessa Pharmaceuticals PLC (CNTA)'s detailed insider trading history can be found in Insider Trading Tracker table.
Centessa Pharmaceuticals PLC Insider Transactions
Saurabh Saha Mailing Address
Above is the net worth, insider trading, and ownership report for Saurabh Saha. You might contact Saurabh Saha via mailing address: C/o Centessa Pharmaceuticals Plc, 3rd Floor, 1 Ashley Road, Altrincham, Cheshire X0 Wa14 2dt.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
